Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine

THOUSAND OAKS, Calif., Sept. 20, 2020 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that updated data from the full Phase 1 cohort of the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 129 patients across

New Zealand lifts Auckland virus lockdown

Schools across Auckland reopened Monday as New Zealand’s largest city emerged from lockdown, with Prime Minister Jacinda Ardern expressing confidence a second-wave outbreak of coronavirus was under control. While Aucklanders were allowed out of their